Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
HOXB9 is a member of the Abd-B homeobox family and encodes a protein with a homeobox DNA-binding domain. Zusätzlich bieten wir Ihnen HOXB9 Proteine (6) und HOXB9 Kits (1) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 83 products:
Human Monoclonal HOXB9 Primary Antibody für IP, ELISA - ABIN516642
Wu, Rupaimoole, Shen, Pradeep, Pecot, Ivan, Nagaraja, Gharpure, Pham, Hatakeyama, McGuire, Haemmerle, Vidal-Anaya, Olsen, Rodriguez-Aguayo, Filant, Ehsanipour, Herbrich, Maiti, Huang, Kim, Zhang, Han et al.: A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer. ... in Nature communications 2016
Human Monoclonal HOXB9 Primary Antibody für ELISA, WB - ABIN516640
Zhan, Niu, Wang, Zhu, Li, Song, He, Wang, Xue, Fang, Zhang: Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients. in British journal of cancer 2014
Human Polyclonal HOXB9 Primary Antibody für ELISA, WB - ABIN4319717
Need, Attix, McEvoy, Cirulli, Linney, Hunt, Ge, Heinzen, Maia, Shianna, Weale, Cherkas, Clement, Spector, Gibson, Goldstein: A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB. in Human molecular genetics 2009
AcK27-HOXB9 suppresses the transcription of its target gene Jumonji domain-containing protein 6 (JMJD6 (zeige JMJD6 Antikörper)) by direct occupying the promoter of JMJD6 (zeige JMJD6 Antikörper) gene.
High expression of HoxB9 is a prognostic marker for lung adenocarcinoma patients.
We also found that FAT10 (zeige UBD Antikörper) may act its oncogenic functions through regulating HOXB9. Collectively, the results suggested that FAT10 (zeige UBD Antikörper) may be a novel therapeutic target for osteosarcoma patients
the results of the present study suggested that HOXB9 is a tumor suppressor in gastric carcinoma, and its activity was controlled by different regulatory mechanisms such as the hexapeptide motif as a "brake" in this case
Expression of GalNAc-T14 (zeige GALNT14 Antikörper) or HOXB9 was strongly correlated with reduced recurrence-free survival in lung adenocarcinomas.
Knock-down of HOXB9 expression decreased migration, invasion and proliferation but did not alter adhesion.
HOXB9 promotes epithelial-to-mesenchymal transition via TGF-beta1 (zeige TGFB1 Antikörper) pathway in hepatocellular carcinoma cells.
Identification of the transcription factor binding site of the HOXB9 promoter region suggests that E2F1 (zeige E2F1 Antikörper) is a direct regulator of HOXB9 expression in breast cancer.
Low HOXB9 expression promotes pancreatic ductal adenocarcinoma progression.
HOXB9 promoted colon adenocarcinoma differentiation.
This gene is a member of the Abd-B homeobox family and encodes a protein with a homeobox DNA-binding domain. It is included in a cluster of homeobox B genes located on chromosome 17. The encoded nuclear protein functions as a sequence-specific transcription factor that is involved in cell proliferation and differentiation. Increased expression of this gene is associated with some cases of leukemia, prostate cancer and lung cancer.
, homeobox gene B-9
, homeobox protein Hox-B9a
, homeobox B9
, homeo box B9
, homeo box 2E
, homeobox protein Hox-2.5
, homeobox protein Hox-2E
, homeobox protein Hox-B9
, homeobox protein
, Homeobox protein Hox-B9